Zobrazeno 1 - 10
of 32
pro vyhledávání: '"Lövgren, Kristina"'
Autor:
Sjödahl G; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden. Electronic address: gottfrid.sjodahl@med.lu.se., Abrahamsson J; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Holmsten K; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Oncology, Capio S:t Göran Hospital, Stockholm, Sweden., Bernardo C; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Chebil G; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Eriksson P; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Johansson I; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Kollberg P; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden., Lindh C; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden., Lövgren K; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Marzouka NA; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Olsson H; Department of Pathology, Department of Clinical and Experimental Medicine, Medical Faculty, Linköping University, Linköping, Sweden., Höglund M; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Ullén A; Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden; Department of Pelvic Cancer, Genitourinary Oncology and Urology unit, Karolinska University Hospital, Stockholm, Sweden., Liedberg F; Department of Translational Medicine, Lund University, Malmö, Sweden; Department of Urology, Skåne University Hospital, Malmö, Sweden.
Publikováno v:
European urology [Eur Urol] 2022 May; Vol. 81 (5), pp. 523-532. Date of Electronic Publication: 2021 Nov 13.
Autor:
Forsare C; Division of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden., Vistrand S; Department of Oncology, Växjö Central Hospital, SE-352 34 Växjö, Sweden., Ehinger A; Division of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.; Department of Clinical Genetics and Pathology, Skåne University Hospital, Lund University, SE-221 85 Lund, Sweden., Lövgren K; Division of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden., Rydén L; Division of Surgery, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.; Department of Surgery, Skåne University Hospital, SE-214 28 Malmö, Sweden., Fernö M; Division of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden., Narbe U; Division of Oncology, Department of Clinical Sciences Lund, Lund University, SE-223 81 Lund, Sweden.; Department of Oncology, Växjö Central Hospital, SE-352 34 Växjö, Sweden.; Department of Oncology, Skåne University Hospital, SE-221 85 Lund, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2022 Feb 14; Vol. 14 (4). Date of Electronic Publication: 2022 Feb 14.
Autor:
Cieśla M; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Ngoc PCT; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Cordero E; Division of Translational Cancer Research, Department of Laboratory Medicine, Faculty of Medicine, Lund University, 22363 Lund, Sweden., Martinez ÁS; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Morsing M; Division of Translational Cancer Research, Department of Laboratory Medicine, Faculty of Medicine, Lund University, 22363 Lund, Sweden., Muthukumar S; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Beneventi G; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Madej M; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Munita R; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Jönsson T; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden., Lövgren K; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Ebbesson A; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Nodin B; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Hedenfalk I; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Jirström K; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Vallon-Christersson J; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Honeth G; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Staaf J; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden., Incarnato D; Faculty of Science and Engineering, University of Groningen, Groningen, the Netherlands., Pietras K; Division of Translational Cancer Research, Department of Laboratory Medicine, Faculty of Medicine, Lund University, 22363 Lund, Sweden., Bosch A; Division of Oncology, Department of Clinical Sciences, Lund University, Lund, Sweden; Department of Hematology, Oncology and Radiation Physics, Skåne University Hospital, Lund, Sweden. Electronic address: ana.bosch_campos@med.lu.se., Bellodi C; Division of Molecular Hematology, Department of Laboratory Medicine, Lund Stem Cell Center, Faculty of Medicine, Lund University, 22184 Lund, Sweden. Electronic address: cristian.bellodi@med.lu.se.
Publikováno v:
Molecular cell [Mol Cell] 2021 Apr 01; Vol. 81 (7), pp. 1453-1468.e12. Date of Electronic Publication: 2021 Mar 03.
Autor:
Jørgensen CLT; Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Medicon Village, Building 404, 22381, Lund, Sweden. charlotte.levin_tykjaer_jorgensen@med.lu.se., Forsare C; Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Medicon Village, Building 404, 22381, Lund, Sweden., Bendahl PO; Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Medicon Village, Building 404, 22381, Lund, Sweden., Falck AK; Department of Surgery, Helsingborg Hospital, Helsingborg, Sweden., Fernö M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Medicon Village, Building 404, 22381, Lund, Sweden., Lövgren K; Division of Oncology and Pathology, Department of Clinical Sciences, Lund, Lund University, Medicon Village, Building 404, 22381, Lund, Sweden., Aaltonen K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University, Lund, Sweden., Rydén L; Division of Surgery, Department of Clinical Sciences, Lund, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Lund, Sweden.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2020 Jun; Vol. 181 (2), pp. 369-381. Date of Electronic Publication: 2020 Apr 16.
Autor:
Sjödahl G; Department of Translational Medicine, Division of Urological Research, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Skåne, Sweden., Eriksson P; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Patschan O; Department of Translational Medicine, Division of Urological Research, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Skåne, Sweden., Marzouka NA; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Jakobsson L; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Bernardo C; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Lövgren K; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Chebil G; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden., Zwarthoff E; Department of Pathology, Erasmus MC Cancer Institute, Erasmus Medical Center, Rotterdam, The Netherlands., Liedberg F; Department of Translational Medicine, Division of Urological Research, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Skåne, Sweden., Höglund M; Division of Oncology and Pathology, Clinical Sciences, Lund University, Lund, Sweden.
Publikováno v:
International journal of cancer [Int J Cancer] 2020 May 01; Vol. 146 (9), pp. 2636-2647. Date of Electronic Publication: 2019 Nov 14.
Autor:
Cabrita R; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Lauss M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Sanna A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Skaarup Larsen M; Department of Clinical Pathology, Herlev University Hospital, Herlev, Denmark., Mitra S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Johansson I; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Phung B; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Harbst K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., van Schoiack A; NanoString Technologies, Seattle, WA, USA., Lövgren K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Warren S; NanoString Technologies, Seattle, WA, USA., Jirström K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Olsson H; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Pietras K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University Cancer Center, Lund University, Lund, Sweden., Ingvar C; Department of Surgery, Skåne University Hospital, Lund, Sweden., Isaksson K; Department of Surgery, Skåne University Hospital, Lund, Sweden., Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany., Schmidt H; Department of Oncology, Århus University Hospital, Aarhus, Denmark., Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark., Carneiro A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.; Department of Oncology, Skåne University Hospital, Lund, Sweden., Wargo JA; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jönsson G; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden. goran_b.jonsson@med.lu.se.
Publikováno v:
Nature [Nature] 2020 Apr; Vol. 580 (7801), pp. E1.
Autor:
Cabrita R; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden., Mitra S; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden., Sanna A; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden., Ekedahl H; Department of Oncology, Skåne University Hospital, 22185 Lund, Sweden., Lövgren K; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden., Olsson H; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden., Ingvar C; Department of Surgery, Skåne University Hospital, 22185 Lund, Sweden., Isaksson K; Department of Surgery, Department of Clinical Sciences, Lund University, 22185 Lund, Sweden.; Department of Surgery, Central Hospital Kristanstad, 29133 Kristainstad, Sweden., Lauss M; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden., Carneiro A; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden.; Department of Oncology, Skåne University Hospital, 22185 Lund, Sweden., Jönsson G; Division of Oncology, Department of Clinical Sciences, Lund University, 22381 Lund, Sweden.
Publikováno v:
Cancers [Cancers (Basel)] 2020 Mar 21; Vol. 12 (3). Date of Electronic Publication: 2020 Mar 21.
Autor:
Cabrita R; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Lauss M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Sanna A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Donia M; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Skaarup Larsen M; Department of Clinical Pathology, Herlev University Hospital, Herlev, Denmark., Mitra S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Johansson I; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Phung B; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Harbst K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Vallon-Christersson J; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., van Schoiack A; NanoString Technologies, Seattle, WA, USA., Lövgren K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Warren S; NanoString Technologies, Seattle, WA, USA., Jirström K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Olsson H; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden., Pietras K; Division of Translational Cancer Research, Department of Laboratory Medicine, Lund University Cancer Center, Lund University, Lund, Sweden., Ingvar C; Department of Surgery, Skåne University Hospital, Lund, Sweden., Isaksson K; Department of Surgery, Skåne University Hospital, Lund, Sweden., Schadendorf D; Department of Dermatology, University Hospital of Essen, Essen, Germany., Schmidt H; Department of Oncology, Århus University Hospital, Aarhus, Denmark., Bastholt L; Department of Oncology, Odense University Hospital, Odense, Denmark., Carneiro A; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden.; Department of Oncology, Skåne University Hospital, Lund, Sweden., Wargo JA; Department of Surgical Oncology, MD Anderson Cancer Center, Houston, TX, USA., Svane IM; National Center for Cancer Immune Therapy, Department of Oncology, Copenhagen University Hospital, Herlev, Denmark., Jönsson G; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University Cancer Center, Lund University, Lund, Sweden. goran_b.jonsson@med.lu.se.
Publikováno v:
Nature [Nature] 2020 Jan; Vol. 577 (7791), pp. 561-565. Date of Electronic Publication: 2020 Jan 15.
Autor:
Narbe U; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden. ulrik.narbe@med.lu.se.; Department of Oncology, Växjö Central Hospital, Växjö, Sweden. ulrik.narbe@med.lu.se., Sjöström M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden., Forsare C; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden., Bendahl PO; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden., Alkner S; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden.; Skåne Clinic of Oncology, Skåne University Hospital, Lund, Sweden., Leeb-Lundberg LMF; Department of Experimental Medical Science, Lund University, Lund, Sweden., Lövgren K; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden., Rydén L; Department of Clinical Sciences, Division of Surgery, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Lund, Sweden., Ingvar C; Department of Clinical Sciences, Division of Surgery, Lund University, Lund, Sweden.; Department of Surgery, Skåne University Hospital, Lund, Sweden., Fernö M; Department of Clinical Sciences, Division of Oncology and Pathology, Lund University, Medicon Village, 223 81, Lund, Sweden.
Publikováno v:
Breast cancer research and treatment [Breast Cancer Res Treat] 2019 Jun; Vol. 175 (2), pp. 305-316. Date of Electronic Publication: 2019 Feb 22.
Autor:
Sjödahl G; Division of Urological Research, Department of Translational Medicine, Lund University, Lund, Sweden. gottfrid.sjodahl@med.lu.se.; Department of Urology, Skåne University Hospital, Malmö, Sweden. gottfrid.sjodahl@med.lu.se., Eriksson P; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Lövgren K; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Marzouka NA; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Bernardo C; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden., Nordentoft I; Department of Molecular Medicine (MOMA), Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark., Dyrskjøt L; Department of Molecular Medicine (MOMA), Department of Clinical Medicine, Aarhus University Hospital and Aarhus University, Aarhus, Denmark., Liedberg F; Division of Urological Research, Department of Translational Medicine, Lund University, Lund, Sweden.; Department of Urology, Skåne University Hospital, Malmö, Sweden., Höglund M; Division of Oncology and Pathology, Department of Clinical Sciences, Lund University, Lund, Sweden.
Publikováno v:
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc [Mod Pathol] 2018 Dec; Vol. 31 (12), pp. 1869-1881. Date of Electronic Publication: 2018 Jul 02.